Our Health Library information does not replace the advice of a doctor. Please be advised that this information is made available to assist our patients to learn more about their health. Our providers may not see and/or treat all topics found herein.
Angioplasty risks
Out of 100 people who have had a coronary angioplasty for stable angina:
About 1 or 2 people had a serious bleeding problem from the procedure.
About 1 to 4 people had damage to a blood vessel from the catheter.
Fewer than 1 out of 100 people (4 out of 1,000) had emergency bypass surgery.
Fewer than 1 out of 100 (2 out of 1,000) had a stroke.
Fewer than 1 out of 100 (1 out of 1,000) died.
These numbers about risks come from problems seen in patients in hospitals.
Current as of: July 31, 2024
Author: Ignite Healthwise, LLC Staff Clinical Review Board All Ignite Healthwise, LLC education is reviewed by a team that includes physicians, nurses, advanced practitioners, registered dieticians, and other healthcare professionals.
Clinical Review Board All Ignite Healthwise, LLC education is reviewed by a team that includes physicians, nurses, advanced practitioners, registered dieticians, and other healthcare professionals.
Lichtman JH, et al. (2014). Age and sex differences in inhospital complications rates and mortality after percutaneous coronary intervention procedures: Evidence from the NCDR. American Heart Journal, 167(3): 376-83. DOI: 10.1016/j.ahj.2013.11.001. Accessed March 23, 2017.
Subherwal S, et al. (2012). Temporal trends in and factors associated with bleeding complications among patients undergoing percutaneous coronary intervention. Journal of the American College of Cardiology, 59(21): 1861–1869. DOI: 10.1016/j.jacc.2011.12.046. Accessed October 16, 2015.
Bernat I, et al. (2019) Best practices for the prevention of radial artery occlusion after transradial diagnostic angiography and intervention: An international consensus paper. Journal of the American College of Cardiology: Cardiovascular Interventions, 12(22): 2235–2246. DOI: 10.1016/j.jcin.2019.07.043. Accessed July 6, 2020.
Kutcher MA, et al. (2009). Percutaneous coronary interventions in facilities without cardiac surgery on site: A report from the National Cardiovascular Data Registry (NCDR). Journal of the American College of Cardiology, 54(1): 16–24. DOI: 10.1016/j.jacc.2009.03.038. Accessed March 23, 2017.
Aggarwal A, et al (2009). Incidence and predictors of stroke associated with percutaneous coronary intervention. American Journal of Cardiology, 104 (3): 349-53. DOI: 10.1016/j.amjcard.2009.03.046. Accessed March 23, 2017.
Vora AN, et al. (2016). Temporal trends in the risk profile of patients undergoing outpatient percutaneous coronary intervention. Circulation Cardiovascular Interventions, 9(3): e003070. DOI: 10.1161/CIRCINTERVENTIONS.115.003070. Accessed March 23, 2017.
This information does not replace the advice of a doctor. Ignite Healthwise, LLC disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use and Privacy Policy. Learn how we develop our content.
To learn more about Ignite Healthwise, LLC, visit webmdignite.com.
I am excited to announce that I will be relocating my practice to Houston Methodist DeBakey Cardiology Associates. Starting November 4, 2024, my new address will be:
5115 Fannin, Suite 801 Houston, TX 77004
Please note that my phone number and fax number will also change to the following: 24-Hour Telephone: 713-441-1100 Fax: 713-790-2643 Clinical Support Telephone (M-F, 8-5): 713-441-3515
I am excited about caring for you in my new office and hope you will make the transition with me. I will also continue to refill your medications as I have in the past. To assist, please provide your pharmacy with my new contact information.
Please consider checking your prescription refills to verify that you have enough medication on hand to last you until your next visit. Please note that your medical records will remain at my former office until you authorize their transfer. If you choose for me to continue providing your medical care, please complete and sign the enclosed “Authorization for Release of Medical Records” form and fax it to 713-790-2643. Once we receive your authorization, we will be happy to process the request for you.
Thank you for entrusting me with your medical care. My new team and I are dedicated to making this transition as seamless as possible. For help scheduling an appointment and transitioning your care, please call my new office number above.
I look forward to continuing your care at my new location.
Sincerely, Gopi A. Shah, MD
Dear patient
Dr. Albert Raizner, Dr. Michael Raizner, and Dr. Mohamed El-Beheary are excited to announce that our practice, Interventional Cardiology Associates, will merge with Houston Cardiovascular Associates on November 1, 2024.
Our new offices are similarly located in Houston, near the Texas Medical Center and in Sugar Land. Our in-hospital care will continue at Houston Methodist Hospital in the Texas Medical Center and Houston Methodist Sugar Land Hospital. Importantly, our new offices expand our services with state-of-the-art equipment and amenities. Our core values will always be, as they began over 40 years ago when Dr. Albert Raizner founded ICA:
Integrity – Compassion – Accountability
Our new address and contact information are:
Houston Office 5115 Fannin Street, Museo Building, Suite 801 Houston, TX 77004 Telephone: 713-790-9125 or 713-790-0841 Fax: 713-790-9663
Sugar Land Office 16605 Southwest Freeway, Medical Office Building 3, Suite 360 Sugar Land, TX 77479 Telephone: 832-833-1705 Fax: 281-973-2228
Your medical records are confidential and remain available at our new locations. We consider it a privilege to serve as your cardiologists and look forward to your continuing with us. However, should you desire to transfer to another physician, you may request a copy of your records by contacting us at our new addresses and phone numbers listed above.
We thank you for your trust and loyalty. As always, we will continue to be here to take care of you. Please do not hesitate to contact us if you have any questions or concerns.
Sincerely,
Dr. Albert Raizner, Dr. Michael Raizner, Dr. Mohamed El-Beheary